18 FDG-PET is an imagining technique based on metabolic criteria rather than
morphological criteria.(18) FDG-PET can demonstrate accelerated glycosis in cancer tissue …

Opinion statement The dissemination of positron emission tomography (PET) technology
has enabled a functional approach to the evaluation of lung cancer that complements the …

This communication presents an update on the current role of positron emission tomography-
computed tomography (PET-CT) in the various clinical decision-making steps in lung …

In pulmonary oncology, positron emission tomography provides metabolic imaging with a
sensitivity and specificity of around 90%. Such results are of particular interest in the …

Abstract 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a useful
technique to characterize the solitary pulmonary nodule, diagnose primary lung cancer …

In the past 5 yrs, positron emission tomography (PET), usually used with 18 F‐fluoro‐2‐
deoxy-glucose (FDG), has become an important imaging modality in lung cancer patients …

Since its introduction in 1974, positron emission tomography (PET) has gained widespread
use, especially in diagnosis and staging of lung cancer. In this respect, 18F …

Positron emission tomography (PET) with 18F‐fluoro‐2‐deoxyglucose (FDG) has recently
emerged as a practical and useful imaging modality in patients with lung cancer. Malignant …

The potential use of positron emission tomography (PET) imaging in patients with non–small
cell lung cancer (NSCLC) is broadly divided into 5 categories: management of solitary …

The availability of clinical positron emission tomography (PET) is increasing rapidly in the
developed world (1). This article reviews the role of PET scanning in lung cancer …